• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long-term carriage of vancomycin-resistant enterococci in patients discharged from hospitals: a 12-year retrospective cohort study.医院出院患者中万古霉素耐药肠球菌的长期携带:一项长达 12 年的回顾性队列研究。
J Clin Microbiol. 2013 Oct;51(10):3374-9. doi: 10.1128/JCM.01501-13. Epub 2013 Aug 7.
2
Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients.从定植或感染患者的单一临床标本培养物中同时分离出耐万古霉素肠球菌和耐甲氧西林金黄色葡萄球菌。
Infect Control Hosp Epidemiol. 2009 Feb;30(2):130-8. doi: 10.1086/593957.
3
Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital.定植时间和出院后万古霉素耐药肠球菌携带时间延长的危险因素。
Int J Infect Dis. 2013 Apr;17(4):e240-6. doi: 10.1016/j.ijid.2012.09.019. Epub 2012 Nov 26.
4
Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden.瑞典住院患者和非住院个体中耐万古霉素肠球菌几乎不存在,但耐喹诺酮耐氨苄西林肠球菌携带率高。
J Clin Microbiol. 1999 Nov;37(11):3509-13. doi: 10.1128/JCM.37.11.3509-3513.1999.
5
Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary.评估匈牙利一家三级保健医院肠内万古霉素耐药肠球菌(VRE)的携带率。
Folia Microbiol (Praha). 2020 Jun;65(3):483-490. doi: 10.1007/s12223-019-00751-x. Epub 2019 Nov 4.
6
[Vancomycin-resistant enterococcus colonization in neonatal intensive care unit: prevention and eradication experience].新生儿重症监护病房耐万古霉素肠球菌定植:预防与根除经验
Mikrobiyol Bul. 2012 Oct;46(4):682-8.
7
Clinical prediction rule for identifying patients with vancomycin-resistant enterococci (VRE) at the time of admission to the intensive care unit in a low VRE prevalence setting.在低万古霉素耐药肠球菌(VRE)流行环境下,用于识别入住重症监护病房时具有 VRE 患者的临床预测规则。
J Antimicrob Chemother. 2012 Dec;67(12):2963-9. doi: 10.1093/jac/dks303. Epub 2012 Aug 10.
8
Risk factors for vancomycin-resistant Enterococcus colonization in hematologic patients.血液学患者中耐万古霉素肠球菌定植的危险因素。
Vojnosanit Pregl. 2013 Dec;70(12):1109-16. doi: 10.2298/vsp1312109m.
9
Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients.儿科肿瘤患者中耐万古霉素肠球菌定植的暴发
Infect Control Hosp Epidemiol. 2009 Apr;30(4):338-45. doi: 10.1086/596202.
10
[Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].[土耳其加济安泰普儿童医院耐万古霉素肠球菌定植情况评估]
Mikrobiyol Bul. 2011 Oct;45(4):646-54.

引用本文的文献

1
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.万古霉素耐药肠球菌血流感染的治疗方法。
Clin Microbiol Rev. 2023 Jun 21;36(2):e0005922. doi: 10.1128/cmr.00059-22. Epub 2023 Apr 17.
2
Predictors of Vancomycin-Resistant spp. Intestinal Carriage among High-Risk Patients in University Hospitals in Serbia.塞尔维亚大学医院高危患者中耐万古霉素 菌属肠道携带的预测因素
Antibiotics (Basel). 2022 Sep 9;11(9):1228. doi: 10.3390/antibiotics11091228.
3
Carriage of vancomycin-resistant in infants following an outbreak in the neonatal intensive care unit: time to clearance of carriage and use of molecular methods to detect colonization.耐万古霉素肠球菌在新生儿重症监护病房爆发后的婴儿中的携带情况:清除携带的时间和使用分子方法检测定植。
Infect Control Hosp Epidemiol. 2023 Mar;44(3):497-500. doi: 10.1017/ice.2021.524. Epub 2022 Jan 31.
4
Resistance in Vancomycin-Resistant Enterococci.耐万古霉素肠球菌的耐药性。
Infect Dis Clin North Am. 2020 Dec;34(4):751-771. doi: 10.1016/j.idc.2020.08.004.
5
State-Wide Genomic and Epidemiological Analyses of Vancomycin-Resistant in Tasmania's Public Hospitals.塔斯马尼亚公立医院耐万古霉素的全州基因组和流行病学分析。
Front Microbiol. 2020 Jan 15;10:2940. doi: 10.3389/fmicb.2019.02940. eCollection 2019.
6
Predictors for vancomycin resistant transforming from colonization to infection: a case control study.从定植感染转变为万古霉素耐药的预测因素:一项病例对照研究。
Antimicrob Resist Infect Control. 2019 Dec 2;8:196. doi: 10.1186/s13756-019-0647-7. eCollection 2019.
7
Nosocomial Outbreak Caused by NDM-5 and OXA-181 Carbapenemase Co-producing .由产NDM-5和OXA-181碳青霉烯酶共同引起的医院感染暴发
Infect Chemother. 2019 Jun;51(2):177-182. doi: 10.3947/ic.2019.51.2.177.
8
Emergence of an Australian-like pstS-null vancomycin resistant Enterococcus faecium clone in Scotland.澳大利亚样 pstS 缺失万古霉素耐药屎肠球菌克隆在苏格兰的出现。
PLoS One. 2019 Jun 13;14(6):e0218185. doi: 10.1371/journal.pone.0218185. eCollection 2019.
9
Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus.危重病期间周围患者使用万古霉素与耐万古霉素肠球菌持续定植的风险。
J Hosp Infect. 2019 Jul;102(3):343-346. doi: 10.1016/j.jhin.2019.01.008. Epub 2019 Jan 11.
10
Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition.在被动监测和主动监测(接触隔离)期间,对万古霉素耐药肠球菌传播的数学建模强调了识别和解决获得源的必要性。
BMC Infect Dis. 2018 Oct 11;18(1):511. doi: 10.1186/s12879-018-3388-y.

本文引用的文献

1
Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge.碳青霉烯类耐药肠杆菌科在出院后的携带时间。
Am J Infect Control. 2013 Mar;41(3):190-4. doi: 10.1016/j.ajic.2012.09.020.
2
Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital.定植时间和出院后万古霉素耐药肠球菌携带时间延长的危险因素。
Int J Infect Dis. 2013 Apr;17(4):e240-6. doi: 10.1016/j.ijid.2012.09.019. Epub 2012 Nov 26.
3
High-resolution melting genotyping of Enterococcus faecium based on multilocus sequence typing derived single nucleotide polymorphisms.基于多位点序列分型衍生的单核苷酸多态性的粪肠球菌高分辨率熔解基因分型。
PLoS One. 2011;6(12):e29189. doi: 10.1371/journal.pone.0029189. Epub 2011 Dec 16.
4
Rectal culture screening for vancomycin-resistant enterococcus in chronic haemodialysis patients: false-negative rates and duration of colonisation.慢性血液透析患者中万古霉素耐药肠球菌直肠培养筛查:假阴性率和定植持续时间。
J Hosp Infect. 2011 Oct;79(2):147-50. doi: 10.1016/j.jhin.2011.04.011. Epub 2011 Jul 20.
5
Evaluation of the duration of vanA vancomycin-resistant Enterococcus faecium carriage and clearance during a large-scale outbreak in a region of eastern France.评估法国东部某地区大规模爆发期间万古霉素耐药粪肠球菌 vanA 携带和清除的持续时间。
Am J Infect Control. 2011 Mar;39(2):169-71. doi: 10.1016/j.ajic.2010.07.003. Epub 2010 Oct 25.
6
A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.万古霉素耐药粪肠球菌血流感染医院持续性暴发:由 vanB 型粪肠球菌 203 序列型导致。
J Infect Dis. 2010 Oct 15;202(8):1278-86. doi: 10.1086/656319.
7
High rates of fecal carriage of nonenterococcal vanB in both children and adults.儿童和成人中非肠球菌vanB粪便携带率均很高。
Antimicrob Agents Chemother. 2008 Mar;52(3):1195-7. doi: 10.1128/AAC.00531-07. Epub 2008 Jan 7.
8
A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice.结直肠肿瘤筛查试验的比较:一项基于社区的多中心消费者选择影响研究。
Med J Aust. 2006 Jun 5;184(11):546-50. doi: 10.5694/j.1326-5377.2006.tb00377.x.
9
Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice.万古霉素抗性转座子Tn1549在悉生小鼠肠道内从共生梭菌转移至肠球菌属。
Antimicrob Agents Chemother. 2006 Mar;50(3):1054-62. doi: 10.1128/AAC.50.3.1054-1062.2006.
10
Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.结直肠癌不同筛查策略的随机试验:患者反应及检出率
J Natl Cancer Inst. 2005 Mar 2;97(5):347-57. doi: 10.1093/jnci/dji050.

医院出院患者中万古霉素耐药肠球菌的长期携带:一项长达 12 年的回顾性队列研究。

Long-term carriage of vancomycin-resistant enterococci in patients discharged from hospitals: a 12-year retrospective cohort study.

机构信息

Department of Epidemiology and Preventive Medicine, Infectious Disease Epidemiology Unit, Monash University, Melbourne, Australia.

出版信息

J Clin Microbiol. 2013 Oct;51(10):3374-9. doi: 10.1128/JCM.01501-13. Epub 2013 Aug 7.

DOI:10.1128/JCM.01501-13
PMID:23926167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3811615/
Abstract

Contact precautions are recommended in hospitals to prevent the transmission of vancomycin-resistant enterococci (VRE); however, there is no clear policy for how long patients should be under contact precautions due to a lack of information on the duration of carriage of these organisms. We conducted a retrospective cohort study to understand the duration of carriage of VRE (by screening of a single stool culture) and associated factors among patients who had been identified with VRE infection and/or colonization since the year 2000 at our health facilities. Of the 345 eligible participants, 136 did not respond, 90 declined to participate, and 16 did not send in the required specimens. Of the 103 remaining participants, 13 were found to have current VRE fecal carriage. The proportion of colonized patients fell from 40% (2/5) in the first year to 23.3% (7/30) in year 4. None of the 40 patients who had VRE detected >4 years prior were found to be colonized at the time of the study. The longest duration of detected VRE positivity was 46.5 months. Univariate analysis revealed that recent exposure to any antibiotics (P = 0.016), multiple antibiotics (P = 0.001), amoxicillin-clavulanic acid (P = 0.021), piperacillin-tazobactam (P = 0.007), glycopeptides (P < 0.001), meropenem (P = 0.007), aminoglycosides (P = 0.021), or fluoroquinolones (P = 0.021), being the index case in a clinical specimen (P = 0.016), and recent hospitalization (P < 0.001) were significantly associated with continued carriage on follow-up. In the surviving outpatients, a significant proportion appeared to clear VRE carriage. Our results suggest that in the absence of recent risk factors, such as hospitalization or antibiotic use, patients with a remote history of colonization (>4 years) may no longer require contact isolation precautions.

摘要

接触预防措施被建议用于医院以预防耐万古霉素肠球菌(VRE)的传播;然而,由于缺乏关于这些生物体携带时间的信息,因此对于患者应接受接触预防措施的时间长短没有明确的政策。我们进行了一项回顾性队列研究,以了解自 2000 年以来在我们的医疗设施中被诊断为 VRE 感染和/或定植的患者中 VRE 的携带时间(通过单次粪便培养筛查)及其相关因素。在 345 名符合条件的参与者中,有 136 人未回复,90 人拒绝参与,16 人未提交所需标本。在剩余的 103 名参与者中,发现 13 人当前具有 VRE 粪便携带。定植患者的比例从第一年的 40%(2/5)下降到第四年的 23.3%(7/30)。在研究时,没有发现 4 年前检测到 VRE 的 40 名患者中有任何定植。检测到的 VRE 阳性持续时间最长为 46.5 个月。单变量分析显示,最近接触任何抗生素(P=0.016)、多种抗生素(P=0.001)、阿莫西林克拉维酸(P=0.021)、哌拉西林他唑巴坦(P=0.007)、糖肽类(P<0.001)、美罗培南(P=0.007)、氨基糖苷类(P=0.021)或氟喹诺酮类(P=0.021)、作为临床标本的索引病例(P=0.016)和最近住院(P<0.001)与随访时的持续携带显著相关。在幸存的门诊患者中,相当一部分似乎清除了 VRE 携带。我们的结果表明,在没有最近的危险因素(如住院或抗生素使用)的情况下,具有 >4 年定植史的患者可能不再需要接触隔离预防措施。